Add Formweb to your mobile device
Ochsner Health COVID-19 SharePoint Site
"Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:
risperiDONE
risperiDONE
- Ambulatory: RisperDAL Consta to Ambulatory Psychiatry
| Drug Name | Form | Strength | Infusion Center Available | Restricted | Non-formulary | Ambulatory Available | Interchange | REMS |
|---|---|---|---|---|---|---|---|---|
| RisperDAL Consta | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 12.5 mg/2 weeks;25 mg/2 weeks; 37.5 mg/2 weeks; 50 mg/2 weeks | ||||||
| RisperiDONE | SOLUTION, ORAL | 1 mg/mL | ||||||
| Uzedy | SUSPENSION, EXTENDED RELEASE, SUBCUTANEOUS | 100 mg/0.28 mL; 125 mg/0.35 mL; 200 mg/0.56 mL; 250 mg/0.7 mL | ||||||
| RisperDAL M-Tab | TABLET, DISINTEGRATING, ORAL | 0.5 mg; 1 mg | ||||||
| RisperiDONE | TABLET, DISINTEGRATING, ORAL | 2 mg; 3 mg; 4 mg | ||||||
| RisperDAL | TABLET, ORAL | 0.25 mg; 1 mg; 2 mg; 4 mg | ||||||
| RisperiDONE | TABLET, ORAL | 0.5 mg; 3 mg |
Last updated: Jan. 27, 2025
- Black Box Warning: Elderly patients with dementia related psychosis
- HazD: PPE, Disposal, and Assessment of Risk
- HazD: Group 2: Non-Antineoplastic
Restricted: RisderDAL Consta is
Pediatric Oral Liquid Standard Concentrations OHS.PHARM.033
Free Trial Drug Program (Long-Acting Injectable Antipsychotics).
*Any inpatient use outside the hospital free drug program is considered nonformulary.